Prestige Consumer Healthcare Inc. (PBH) |
| 52.47 1.26 (2.46%) 08-28 16:00 |
| Open: | 51.5 |
| High: | 52.52 |
| Low: | 51.23 |
| Volume: | 299,756 |
| Market Cap: | 2,486(M) |
| PE Ratio: | 11.87 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Pharmaceuticals |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 55.99 |
| Resistance 1: | 53.33 |
| Pivot price: | 51.67 |
| Support 1: | 49.03 |
| Support 2: | 40.79 |
| 52w High: | 71.07 |
| 52w Low: | 42.62 |
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
| EPS | 3.570 |
| Book Value | 40.460 |
| PEG Ratio | 1.57 |
| Gross Profit | 12.776 |
| Profit Margin (%) | 15.57 |
| Operating Margin (%) | 20.83 |
| Return on Assets (ttm) | 4.6 |
| Return on Equity (ttm) | 9.1 |
Mon, 24 Aug 2026
Prestige Consumer Healthcare Inc. (PBH) Investor Outlook: Exploring a 32% Upside Potential - DirectorsTalk Interviews
Wed, 19 Aug 2026
Is Prestige Consumer Healthcare’s (PBH) Upgraded 2027 Outlook and Halted Buybacks Reframing Its Growth Story? - webull.com
Thu, 13 Aug 2026
Prestige Consumer Healthcare (PBH) Q1 2027 Earnings Call Transcript - AOL.com
Mon, 10 Aug 2026
Prestige Consumer Executives Set for Aug. 12 Fireside Chat - Stock Titan
Thu, 06 Aug 2026
Prestige Consumer Healthcare Inc. 2027 Q1 - Results - Earnings Call Presentation (NYSE:PBH) 2026-08-06 - Seeking Alpha
Thu, 06 Aug 2026
Prestige Consumer Healthcare (PBH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |